Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-04-11
1976-02-10
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3119
Patent
active
039378390
ABSTRACT:
The topical application of 7-(5.alpha.-hydroxy-2.beta.-[(3RS)-3-hydroxy-3-methyl-trans-1-octenyl]-3.a lpha.-methyl-1.alpha.-cyclopentyl)-cis-5-heptenoic acid, 7-(5.alpha.-hydroxy-2.beta.-[(3RS)-3-hydroxy-3-methyl-trans-1-octenyl]-1.a lpha.-cyclopentyl)-cis-5-heptenoic acid, or 7-(2.beta.-[(3RS)-hydroxy-3-methyl-trans-1-octenyl]-5-oxo-1.alpha.-cyclope ntyl)-cis-5-heptenoic acid to a wound surface can be employed to attenuate bleeding. The compounds are prepared from the prostaglandin PGA.sub.2.
REFERENCES:
patent: 3707548 (1972-12-01), Bagli et al.
Fenichei Richard L.
Kao Wenling
Strike Donald P.
American Home Products Corporation
Frankhouser David E.
Rosen Sam
LandOfFree
Method for attenuating bleeding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for attenuating bleeding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for attenuating bleeding will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-150485